Last reviewed · How we verify
Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.
This is a phase III study for evaluation of Nasotestt efficacy compared to Androgel in the treatment of male participants with hypogonadism condition (reduced levels of testosterone) that have clinical indication of hormonal replacement with testosterone.
Details
| Lead sponsor | FBM Industria Brasileira Ltda |
|---|---|
| Phase | PHASE3 |
| Status | UNKNOWN |
| Enrolment | 228 |
| Start date | Mon Jul 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Hypogonadism
Interventions
- Nasotestt 5 mg
- Androgel 50 mg
- Nasotestt Placebo
- Androgel Placebo